Instillido (Lidocaine Hydrochloride)

Lidocaine hydrochloride works by reversibly blocking voltage‑gated sodium channels on nerve fibers. This inhibition prevents the initiation and conduction of nerve impulses, thereby stopping pain signals from reaching the brain in the area where the drug is applied.

The specific dose of Instillido is determined by the prescribing clinician based on the procedure, patient size, and clinical judgment. Healthcare professionals calculate the appropriate amount to achieve effective urethral anesthesia while staying within safe exposure limits.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider after evaluating the individual situation.

To order Instillido, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Instillido delivers lidocaine, an amide‑type local anesthetic with rapid onset and moderate duration. Compared with ester‑type agents such as procaine, lidocaine generally offers a faster onset, longer analgesic effect, and a lower incidence of allergic reactions, making it a preferred choice for urethral procedures.

Instillido should be stored below 25 °C in its original packaging, protected from moisture and direct light. Keep the container tightly closed when not in use and avoid exposure to extreme temperatures to maintain product stability.

Instillido is administered directly into the urethra as a solution. The healthcare professional instills the prescribed volume using a sterile catheter or syringe, allowing the lidocaine to coat the urethral mucosa and produce localized anesthesia before the intended procedure.

The most serious risks include systemic lidocaine toxicity, which can manifest as seizures, cardiac arrhythmias, or severe hypotension, and allergic reactions that may progress to anaphylaxis. Prompt recognition and immediate medical intervention are essential if these events occur.

Instillido should be avoided in individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, patients with severe hepatic impairment, and those with significant cardiac conduction disorders unless the benefit outweighs the risk and close monitoring is possible.